CO-VALID TAB 160/25 MG

Co-Valid is a combination tablet containing Valsartan 160 mg, an angiotensin II receptor blocker (ARB), and Hydrochlorothiazide 25 mg, a thiazide diuretic. It is designed to lower high blood pressure by relaxing blood vessels and helping the body eliminate excess sodium and water. This dual‐action helps achieve better blood pressure control in adults when monotherapy alone is not sufficient.

Uses

• Treatment of essential hypertension (high blood pressure) in adults.

• Use as initial therapy in patients likely to need multiple drugs to reach blood pressure targets.

• Can help reduce risks associated with uncontrolled hypertension, such as stroke, heart attack and kidney damage.

Benefits

• Combines two mechanisms—vasodilation plus fluid reduction—for effective pressure reduction.

• Simplifies therapy by combining both agents in one tablet, improving patient compliance.

• May require fewer pills overall, which can help with treatment adherence.

• Supports long‐term cardiovascular and renal health by maintaining target blood pressure.

Side Effects

• Common: dizziness, headache, fatigue, increased urination, cough, tummy upset.

• Potential: electrolyte imbalance (especially low sodium, potassium changes), dehydration, changes in kidney function.

• Rare but serious: angioedema (swelling of face/lips/tongue), severe drop in blood pressure leading to fainting, allergic reactions.

Precautions

• Only use under a doctor’s supervision. Not suitable during pregnancy; avoid if planning pregnancy.

• Inform your doctor if you have kidney disease, liver disease, gout, diabetes, or low blood volume.

• Monitor blood pressure and kidney/electrolyte tests regularly.

• Avoid excessive salt or potassium supplements unless advised.

• Take at the same time each day; can be with or without food. Do not double up if you miss a dose—seek doctor’s advice.